One pill to rule two? combo drug tested in healthy men
NCT ID NCT01764178
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-stage trial tested whether a single pill containing two medicines (pitavastatin for cholesterol and valsartan for blood pressure) works the same in the body as taking the two pills separately. Fifty-two healthy men took both versions in random order. The study only measured drug levels in the blood, not actual treatment effects or long-term safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pitavastatin and Valsartan (combined in one pill vs. separate pills)
What this could lead to
If the combination pill works as well as separate pills, it could simplify daily dosing for people with high cholesterol and high blood pressure.
What could go wrong
This is a very early, small study in healthy men only. It only checks how the drug moves through the body, not whether it actually treats disease or is safe long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 138-736, South Korea